Healthy volunteers help test dupilumab manufacturing change
NCT ID NCT05976386
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 27 times
Summary
This study tested whether a new version of the drug dupilumab works the same as the current version in healthy adults aged 18 to 65. Participants received a single injection of either the new or current drug, and researchers measured drug levels in the blood and checked for side effects. The study did not aim to treat any disease, but to ensure the new version is safe and comparable to the existing one.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Pharmacology of Miami-Site Number:8400001
Miami, Florida, 33014, United States
Conditions
Explore the condition pages connected to this study.